Related Experiment Videos
Transcription factor expression and cellular redox in immature oligodendrocyte cell death: effect of Bcl-2
Una F FitzGerald1, Tom Gilbey, Suzanne Brodie
1Department of Neurology and Department of Medical Oncology, Garscube Estate, Switchback Road, Glasgow G61 1BD, Scotland.
Abstract:
Multiple sclerosis (MS) is characterized by the progressive damage or loss of oligodendrocytes. In an effort to better understand the causes of oligodendrocyte destruction in MS plaques, we treated immature oligodendrocytes with glucose oxidase, ceramide, or brefeldin A. These treatments model the different mechanisms by which oligodendrocytes are thought to die. We report that the AP-1 and Egr-1 transcription factors are induced within an hour of treatment. Of the AP-1 proteins studied, c-Jun was expressed at the highest level, followed by JunD, c-Fos, and Fra-2, although different treatments induced slightly different levels of expression. Bcl-2 overexpression protects against all treatments, to differing degrees. Although Bcl-2 did not have a dramatic effect on AP-1 or Egr-1 induction within the first 3 h, it caused a lowering of steady-state redox levels with a concomitant increase in cellular glutathione. We propose that the lowering of cellular redox and the upregulation of glutathione are responsible in part for the protective properties of Bcl-2.
Insights
This study investigates oligodendrocyte death in multiple sclerosis (MS). Bcl-2 overexpression protects these cells by lowering redox levels and increasing glutathione, suggesting a novel therapeutic avenue for MS.
Area of Science:
- Neuroscience
- Cell Biology
- Immunology
Background:
- Multiple sclerosis (MS) involves progressive oligodendrocyte damage.
- Understanding oligodendrocyte death mechanisms is crucial for MS treatment.
Purpose of the Study:
- To investigate the molecular mechanisms of oligodendrocyte destruction in MS.
- To explore the role of transcription factors AP-1 and Egr-1 in oligodendrocyte cell death.
- To evaluate the protective effects of Bcl-2 overexpression.
Main Methods:
- Immature oligodendrocytes were treated with glucose oxidase, ceramide, or brefeldin A to model cell death pathways.
- Expression levels of AP-1 proteins (c-Jun, JunD, c-Fos, Fra-2) and Egr-1 were analyzed.
- The impact of Bcl-2 overexpression on cell survival, transcription factor induction, redox levels, and glutathione was assessed.
Main Results:
- AP-1 and Egr-1 transcription factors were rapidly induced by cell death-inducing treatments.
- c-Jun was the most highly expressed AP-1 protein.
- Bcl-2 overexpression conferred protection against all tested treatments.
- Bcl-2 overexpression lowered steady-state redox levels and increased cellular glutathione.
Conclusions:
- The rapid induction of AP-1 and Egr-1 are early events in oligodendrocyte death.
- Bcl-2's protective effects may be mediated by modulating cellular redox balance and glutathione levels.
- These findings suggest potential therapeutic strategies targeting redox homeostasis in MS.